TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹9,620 Cr | ₹8,508 Cr | ₹8,005 Cr | ₹7,939 Cr | ₹7,673 Cr |
What is the latest Revenue of TORRENT PHARMACEUTICALS ?
Year | Revenue |
---|---|
Mar2024 | ₹9,620 Cr |
Mar2023 | ₹8,508 Cr |
Mar2022 | ₹8,005 Cr |
Mar2021 | ₹7,939 Cr |
Mar2020 | ₹7,673 Cr |
How is Revenue of TORRENT PHARMACEUTICALS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹9,620 Cr | 13.07 | |
Mar2023 | ₹8,508 Cr | 6.29 | |
Mar2022 | ₹8,005 Cr | 0.82 | |
Mar2021 | ₹7,939 Cr | 3.47 | |
Mar2020 | ₹7,673 Cr | - |
Compare Revenue of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹110,330.2 Cr | 3.4% | 0.5% | 12.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,768.0 Cr | 0.4% | -1.2% | 12.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,468.0 Cr | 2.6% | 8.4% | 48.5% | Stock Analytics | |
CIPLA | ₹121,326.0 Cr | -0.1% | 0.5% | 1.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,757.0 Cr | 3.2% | 11.8% | 11.4% | Stock Analytics | |
MANKIND PHARMA | ₹98,512.2 Cr | 1.4% | -6.4% | 11.8% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | 3.4% |
0.5% |
12.8% |
SENSEX | 0.3% |
0.7% |
8.8% |
You may also like the below Video Courses